1
Breton Lionel, Leclaire Jacques, Grollier Jean Francois: Composition cosmetique ou pharmaceutique contenant de lacide hyaluronique, et procede cosmetique pour diminuer les signes du vieilissement. Oreal, February 20, 2009: FR2920000-A1 (40 worldwide citation)

L'invention concerne une composition cosmétique ou pharmaceutique qui contient, dans un milieu physiologiquement acceptable, au moins(i) de l'acide hyaluronique et/ou l'un de ses dérivés et (ii) un dérivé C-glycoside, au moins l'un des constituants (i) ou (ii) étant sous une forme adaptée à l'admini ...


2
Breton Lionel, Leclaire Jacques, Grollier Jean François: (Fr) Composition cosmétique ou pharmaceutique contenant de lacide hyaluronique, et procédé cosmétique pour diminuer les signes du vieillissement, (En) Cosmetic or pharmaceutical composition containing hyaluronic acid and cosmetic method for reducing aging signs. L Oreal, Breton Lionel, Leclaire Jacques, Grollier Jean François, ALLAB Myriam, February 26, 2009: WO/2009/024719 (27 worldwide citation)

(EN) The invention relates to a cosmetic or pharmaceutical composition that contains, in a physiologically acceptable medium, at least (i) hyaluronic acid and/or a derivative thereof and (ii) a C-glycoside derivative, wherein at least one of the constituents (i) and (ii) is in a form adapted for adm ...


3
Breton Lionel, Aubert Lucien, Leclaire Jacques, Martin Richard, de Lacharriere Olivier: Use of extracts of filamentous, non photosynthetic bacteria and the composition containing them. Oreal, March 12, 1997: EP0761204-A1 (21 worldwide citation)

The following are claimed: (1) use of extracts (I) of non-photosynthetic filamentous bacteria as substance P antagonists in cosmetic compsns. or for prepn. of pharmaceutical compsns.; (2) cosmetic or pharmaceutical compsns. contg. (I) and prods. (II) with an irritant effect; (3) cosmetic or pharmace ...


4
De Lacharriere Olivier, Breton Lionel: Cosmetic composition comprising an antagonist of substance p.. Oreal, November 8, 1995: EP0680749-A2 (19 worldwide citation)

The use of a substance P antagonist (I) in a cosmetically-acceptable medium for application to sensitive skin is new.


5
Breton Lionel, Jourdain Roland, Gueniche Audrey, Bureau Franz Isabelle, Blum Sperisen Stephanie: Process and compositions for the protection and/or the treatment of dry and/or sensitive skin. Oreal, Nestec, December 28, 2005: EP1609463-A1 (19 worldwide citation)

The use of one or more probiotic microorganisms and/or their fractions and/or their metabolites in association with one or more divalent mineral cations other than sulfate to make compositions for oral administration to treat and/or prevent dry skin or compositions for application for the same purpo ...


6
Breton Lionel, Lacharriere Olivier de: Use of dehydroepi-androsterone in cosmetic or dermatologic composition. Oreal, July 31, 1996: EP0723775-A1 (18 worldwide citation)

Use of dehydro-epi-androsterone sulphate (I) in a topical compsn. for treating wrinkles and fine lines, combatting cutaneous and/or subcutaneous slackness and/or reviving the appearance of the skin is new. Also claimed is the use of (I) in conjunction with at least one active ingredient selected fro ...


7
Smith Rory James Maxwell, Mcritchie Allan Campbell, Breton Lionel: Solid detergent composition for improved greasy soil removal.. Procter & Gamble, January 10, 1979: EP0000225-A1 (16 worldwide citation)

Built laundry detergent compositions containing specific mixtures of selected anionic, nonionic and water-soluble cationic surfactants. The compositions are especially effective in removing greasy soil from fabrics.


8
Mahe Yann, Billoni Nelly, Breton Lionel, Bui Bertrand Lien: Anti-inflammatory composition. Oreal, January 19, 2000: EP0972522-A1 (16 worldwide citation)

A composition (I) comprising an efficient quantity of at least a biologically functional peptide derivative of alpha -melanocyte stimulating hormone ( alpha -MSH) and at least a marine algae extract. Independent claims are also included for the following: (1) use of (I) for the preparation of a comp ...


9
Pineau Nathalie, Martin Richard, Breton Lionel, Aubert Lucien: Cosmetic or pharmaceutical composition containing a microorganism culture medium. Oreal, November 11, 1998: EP0876813-A1 (15 worldwide citation)

Cosmetic and pharmaceutical composition (I) comprises a clarified and stabilised culture medium of a non-photosynthesising filamentous bacterium, and a pharmaceutical or cosmetic support.


10
Breton Lionel, de Lacharriere Olivier: Use of alkaline earth metal salts as tnf-alpha inhibitor in a topical composition and composition obtained therefrom. Oreal, October 16, 1996: EP0737471-A2 (13 worldwide citation)

The use of at least one salt of at least one alkaline earth metal as an inhibitor of Tumour Necrosis Factor- alpha (TNF- alpha ) in a cosmetic, pharmaceutical, dermatological or veterinary composition (I), is new. Also claimed is the use of a strontium salt in a cosmetic, pharmaceutical, dermatologi ...